Andere Sprachen IDEXX Laboratories, Inc.

Aktien

888210

US45168D1046

IDXX

Medizinische Versorgung

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 10.04.2026			% 5 Tage	Veränd. 1. Jan.
563,00 ^USD	-3,72 %		-1,15 %	-16,78 %

01.04.	Idexx Laboratories führt Krebs-Diagnosepanel zur Früherkennung von Lymphomen bei Hunden im Vereinigten Königreich ein	MT
01.04.	Idexx Laboratories, Inc. führt Cancer Dx Panel zur Früherkennung von caninen Lymphomen im Vereinigten Königreich ein	CI

Andere Sprachen

08.04.	IDEXX Laboratories to Release 2026 First Quarter Financial Results
01.04.	Idexx Laboratories' Cancer Dx Panel for Canine Lymphoma Early Detection Available in the UK
01.04.	Idexx Laboratories, Inc. Announces Uk Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma
01.04.	IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma
26.03.	IDEXX Laboratories, Inc. Announces Departure of Nimrata Hunt as Executive Vice President, Global Strategy and Commercial, Effective April 13, 2026
18.03.	Immucell Corporation Announces Changes to Its Board, Effective April 1, 2026
12.03.	Wall Street : repli moyen de -1,6%, tous les supports lâchent prise
02.03.	IDEXX Laboratories : Raymond James Institutional Investors Conference Presentation
24.02.	DENTSPLY SIRONA Inc. Announces Board Changes
20.02.	Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.
13.02.	IDEXX Laboratories, Inc. Announces Retirement of M. Anne Szostak as Director
12.02.	IDEXX Laboratories to Present at Two Institutional Investor Conferences
12.02.	Zoetis forecasts strong 2026 profit, revenue on steady pet-medicine demand
12.02.	Zoetis forecasts upbeat 2026; pet-care market pressure drags shares
12.02.	Zoetis forecasts upbeat 2026; pet-care market pressure drags shares
04.02.	Piper Sandler Companies Elects Stuart M. Essig to its Board of Directors and Audit Committee, Effective as of February 4, 2026
04.02.	Wall Street: When AI Stops Being a Buzzword and Starts Being a Threat
02.02.	Consumer Staples, Consumer Discretionary Help Push US Equity Indexes Higher
02.02.	IDEXX Laboratories, Inc. Provides Earnings Guidance for the Full Year 2026
02.02.	IDEXX forecasts 2026 above estimates, but cautious clinic visit outlook weighs on shares
02.02.	IDEXX Laboratories : Prepared remarks FY 2025
02.02.	IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics
02.02.	IDEXX Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
02.02.	Stocks Fall Pre-Bell as Traders Await Fresh Labor Market Data, Corporate Earnings
02.02.	IDEXX Laboratories Q4 Comparable Earnings, Revenue Rise; Issues 2026 Guidance